Parsons Capital Management’s Bio-Techne TECH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $474K | Sell |
6,712
-140
| -2% | -$7.56K | 0.02% | 381 |
|
|
2026
Q1 | $358K | Hold |
6,852
| – | – | 0.02% | 390 |
|
|
2025
Q4 | $403K | Hold |
6,852
| – | – | 0.02% | 351 |
|
|
2025
Q3 | $381K | Hold |
6,852
| – | – | 0.02% | 355 |
|
|
2025
Q2 | $353K | Hold |
6,852
| – | – | 0.02% | 350 |
|
|
2025
Q1 | $402K | Hold |
6,852
| – | – | 0.02% | 333 |
|
|
2024
Q4 | $494K | Hold |
6,852
| – | – | 0.03% | 319 |
|
|
2024
Q3 | $548K | Hold |
6,852
| – | – | 0.03% | 311 |
|
|
2024
Q2 | $491K | Hold |
6,852
| – | – | 0.03% | 317 |
|
|
2024
Q1 | $482K | Hold |
6,852
| – | – | 0.03% | 322 |
|
|
2023
Q4 | $529K | Hold |
6,852
| – | – | 0.04% | 302 |
|
|
2023
Q3 | $466K | Sell |
6,852
-288
| -4% | -$22.8K | 0.04% | 303 |
|
|
2023
Q2 | $583K | Hold |
7,140
| – | – | 0.04% | 279 |
|
|
2023
Q1 | $530K | Hold |
7,140
| – | – | 0.04% | 286 |
|
|
2022
Q4 | $592K | Hold |
7,140
| – | – | 0.05% | 268 |
|
|
2022
Q3 | $507K | Hold |
7,140
| – | – | 0.05% | 269 |
|
|
2022
Q2 | $619K | Sell |
7,140
-136
| -2% | -$12.7K | 0.06% | 252 |
|
|
2022
Q1 | $788K | Hold |
7,276
| – | – | 0.06% | 242 |
|
|
2021
Q4 | $941K | Hold |
7,276
| – | – | 0.07% | 227 |
|
|
2021
Q3 | $881K | Hold |
7,276
| – | – | 0.07% | 235 |
|
|
2021
Q2 | $819K | Hold |
7,276
| – | – | 0.06% | 238 |
|
|
2021
Q1 | $695K | Hold |
7,276
| – | – | 0.06% | 242 |
|
|
2020
Q4 | $578K | Hold |
7,276
| – | – | 0.05% | 246 |
|
|
2020
Q3 | $451K | Hold |
7,276
| – | – | 0.04% | 250 |
|
|
2020
Q2 | $480K | Buy |
7,276
+2,132
| +41% | +$128K | 0.05% | 237 |
|
|
2020
Q1 | $244K | Hold |
5,144
| – | – | 0.03% | 280 |
|
|
2019
Q4 | $282K | Hold |
5,144
| – | – | 0.03% | 299 |
|
|
2019
Q3 | $252K | Hold |
5,144
| – | – | 0.03% | 308 |
|
|
2019
Q2 | $268K | Hold |
5,144
| – | – | 0.03% | 299 |
|
|
2019
Q1 | $255K | Buy |
+5,144
| New | +$231K | 0.03% | 307 |
|
|
2018
Q4 | – | Sell |
-5,144
| Closed | -$262K | – | 355 |
|
|
2018
Q3 | $262K | Buy |
+5,144
| New | +$228K | 0.03% | 326 |
|
|
2015
Q2 | – | Sell |
-4,800
| Closed | -$120K | – | 511 |
|
|
2015
Q1 | $120K | Buy |
+4,800
| New | +$114K | 0.02% | 366 |
|
Other funds holding TECH
HI
Parsons Capital Management's TECH Position: Q2 2026 in Review
Parsons Capital Management reduced its Bio-Techne (TECH) stake by 2% in Q2 2026, selling an estimated $7.56K and leaving 6,712 shares worth $474K. The position accounts for 0.02% of the portfolio, ranked #381.
Parsons Capital Management first reported a position in TECH in Q1 2015 and has held it in 32 quarters since. The position peaked at $941K in Q4 2021. 596 funds tracked by Wall St. Rank hold TECH as of Q2 2026.
- Parsons Capital Management held 6,712 shares of Bio-Techne worth $474K as of Q2 2026.
- Parsons Capital Management sold 140 Bio-Techne shares in Q2 2026, an estimated $7.56K.
- Bio-Techne made up 0.02% of Parsons Capital Management's portfolio in Q2 2026, its #381 holding.
- Parsons Capital Management first reported a position in Bio-Techne in Q1 2015 and has held it in 32 quarters since.
- Parsons Capital Management's Bio-Techne position peaked at $941K in Q4 2021.
- 596 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.
Based on Parsons Capital Management's 13F filing for Q2 2026, filed 24 Jul 2026.